Purdue Pharma's Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation, according to people with knowledge of confidential mediation discussions.
Certain members of the Sackler family who own Purdue have agreed to boost their total contribution to roughly $6.5 billion over time, the people said, up from $6 billion under a previous plan that was rejected last year by the Supreme Court.
Purdue has been trying since to craft a new path out of bankruptcy since last year's ruling, in which the Supreme Court found that people who rejected the Sacklers' offer in favor of pursuing lawsuits against them couldn't be barred from doing so and forced to accept the settlement terms.
This story is from the January 14, 2025 edition of The Wall Street Journal.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the January 14, 2025 edition of The Wall Street Journal.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In